NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • A Guide to What We Do
    • Activities during COVID-19
    • Strategic Partnership Board
    • Steering Committee
    • Promoting Equality, Diversity and Inclusion in Research
    • Current Vacancies
    • Contact Us
    • Stay in Touch
  • Research
        • OUR 20 RESEARCH THEMES

        • Antimicrobial Resistance and Modernising Microbiology
        • Cardiovascular
        • Clinical Informatics and Big Data
        • Diabetes and Metabolism
        • Gastroenterology and Mucosal Immunity
        • Genomic Medicine
        • Haematology and Stem Cells
        • Imaging
        • Molecular Diagnostics
        • Multi-Modal Cancer Therapies
        • Multi-Morbidity and Long-Term Conditions
        • Musculoskeletal
        • Neurological Conditions
        • Obesity, Diet and Lifestyle
        • Partnerships for Health, Wealth and Innovation
        • Respiratory
        • Stroke and Vascular Dementia
        • Surgical Innovation and Evaluation
        • Technology and Digital Health
        • Vaccines for Emerging and Endemic Diseases
        • Oxford Biomedical Research Centre activities during COVID-19
  • Patient & Public Involvement
    • Getting involved with research
    • Researcher Guidance
    • Post an opportunity for patient and public involvement
  • Training Hub
    • Training Hub Overview
    • Clinical Academic Pathway
    • Internships
    • Preparatory Research Fellowships
    • Senior Research Fellowships
    • Research Training Bursaries
    • Doctoral Awards
    • Post-Doctoral Awards
    • Other funding
    • Leadership Training
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • What Can We Do For Your Organisation?
    • Who Do We Work With?
    • IP and Licensing
    • Contacts for Industry
  • Videos
  • News
  • Events

News

You are here: Home > Haematology and Stem Cells > Researchers thank Bloodwise fundraisers for funding critical leukaemia trial

Researchers thank Bloodwise fundraisers for funding critical leukaemia trial

11 October 2017 · Listed under Haematology and Stem Cells, Other News

Staff and patients at the Oxford Cancer Centre at the Churchill Hospital have thanked fundraisers for the Bloodwise charity who have raised enough money to fully fund a trial of a new leukaemia drug.

The staff and patient Thelma, who has been on the trial, sent their appreciation in a video to Bloodwise after fundraisers, led by actor Sam Heughan, took part in My Peak Challenge and raised more than £300,000 to fund the Camellia trial.

The Camellia trial, run at the Churchill Hospital, is looking at a new drug called Hu5F9-G4 to treat acute myeloid leukaemia (AML) and myelodysplastic Syndrome (MDS).

Hu5F9-G4 is a type of biological therapy known as a monoclonal antibody. It works by blocking the signals of a protein called CD47, which can stop the body’s immune system from working and destroying cancer cells.

The Chief Investigator on the trial is University of Oxford Professor of Haematology Professor Paresh Vyas, who is Theme Lead at the NIHR Oxford BRC for Molecular Diagnostics.

He said: “The Oxford University Hospitals Foundation NHS Trust, Oxford University and the NIHR Oxford BRC are extremely proud to bring new treatments to improve patient lives. This is just one example where we have worked with our partners in the UK and abroad to bring a completely new treatment for patients with Acute Myeloid Leukaemia, the most common aggressive adult leukaemia. It is early days but we are seeing patients benefitting and this is really pleasing.”

Alasdair Rankin, director of research at Bloodwise, said: “We made this video to thank some of our fantastic fundraisers. Camellia is one example of the great research projects that Bloodwise funds in Oxford. We’re grateful to everyone in the Oxford community who supports our vital research – we couldn’t do it without you.”

← Experts meet in Oxford to discuss Responsible Research and Innovation
MDS Patient Support Group learn more about treatment of condition →

News

  • BRC study outlines researchers training needs and barriers 20 May 2022
  • Three new Blood and Transplant Research Units created in Oxford 18 May 2022
  • Oxford’s medical, health and life sciences research excellence recognised 12 May 2022
See full news archive

News Categories

Month Archives

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Oxford BRC on Social Media

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

  • Sitemap
  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2022 NIHR Oxford Biomedical Research Centre